NCT06259097PHASE3Recruiting
Different Medications to Induce Labor
Icahn School of Medicine at Mount Sinai
Start Date
7/2/2024
Completion Date
8/1/2026
Summary
This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.
Detailed Description
This randomized controlled trial will include patients with a BMI greater than 30 at the time of admission for their induction of labor. Patients will be randomized to either misoprostol or Pitocin to begin induction of labor, alongside the standard foley catheter, and the primary outcome of interest will be length of time from start of induction until delivery.
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
\- Pregnant patient presenting to labor \& delivery for induction of labor with a BMI \> = 30
Exclusion Criteria:
\- Pregnant patient presenting to labor \& delivery for induction of labor with BMI \< 30
Interventions
DRUG
Misoprostol
DRUG
Pitocin
Conditions
PregnancyLabor
Locations
Mount Sinai Hospital
New York, New York 10029
United States
Bronx Care Health System
The Bronx, New York 10457
United States